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Abstract
Aim and Objectives: The present investigation was aimed to study antibiotic 
susceptibility pattern of Streptococcus mutans and to fi nd the alternate antimicrobials of 
plant origin.
Methods: The evaluation of the current eﬃ  cacy of 15 commercially available 
antibacterial drugs was carried out against 30 strains of S. mutans by Kirby-Bauer disc 
diﬀ usion method and determined inhibitory activity of medicinal plants Cinnamomum 
zeylanicum, Acacia catechu, Mimusops elengi, and Terminalia arjuna against the clinical 
isolates.
Results: Among 15 antibacterial drugs evaluated against all the strains of S. mutans, 
chloramphenicol and amoxicillin were highly eﬀ ective in terms of maximum diameter of 
growth inhibition zone followed by erythromycin and ciprofl oxacin. Six drugs, namely, 
tetracycline, vancomycin, spectinomycin, ampicillin (AM), clindamycin, and cefuroxime 
exhibited moderate eﬀ ect, and mild eﬀ ect was shown by bacitracin. Whereas cefi xime 
and kanamycin were not eﬀ ective against the bacteria as they did not show any inhibitory 
activity. Among the antimicrobial combinations used: The greatest potency was shown 
by AM/sulbactam. Acetone extract of C. zeylanicum and ethanol extract of A. catechu 
showed a signifi cant antibacterial activity against S. mutans followed by M. elengi and 
T. arjuna.
Conclusion: Further study is required to isolate and characterize bioactive molecule 
from these plants which can be used as an alternative medicine to prevent caries infection.
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Introduction
The oral cavity is a habitat to diverse microfl ora that colonizes 
various mucosal surfaces including teeth. Certain bacterial 
species have been implicated in oral diseases such as dental caries 
and periodontitis, which are among the most common biofi lm-
dependent bacterial infections in humans.[1] Dental caries is an 
infectious disease where bacterial metabolic processes damage 
dental hard tissue structure and is marked by localized progressive 
demineralization of the crown and root surfaces of the tooth. It 
is considered as a major public health problem globally due to its 
high prevalence and signifi cant social impact. The World Health 
Organization reports 60-90% of school children worldwide have 
experienced caries, with the disease being the most prevalent 
in Asian and Latin American countries.[2] Considerable 
epidemiologic evidence links Streptococcus to caries, and 
numerous laboratory investigations demonstrated the ability of 
the species to produce the lactic acid which causes dental caries. 
Streptococcus mutans present in oral fl ora is more prevalent 
in dental caries subjects than Streptococcus sobrinus[3] and has 
been demonstrated to be a causative specialist for dental caries 
because of its capacity to metabolize fermentable carbohydrate 
into organic acids. These acids can cause a fall in pH, which can 
lead to an increase of enamel solubility that is dental caries.[4]
In recent years, multiple drug resistance has been developed 
in both human and plant pathogenic microorganisms due to 
indiscriminate use of commercial antibacterial drugs commonly 
used in the treatment of infectious diseases.[5] The resistance of 
numerous bacterial pathogens to many antibiotics continues 
to increase globally. Frequencies, pattern, and distribution of 
resistant bacteria vary signifi cantly with geographic regions and 
often refl ect the usage patterns of antibiotics.[6] Inappropriate 
antibiotic prescribing and its use have been identifi ed as major 
factors in the emergence of antibiotic resistance. Nowadays, 
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a shift from narrow spectrum antibiotic prescriptions which 
included penicillin to broad-spectrum aminopenicillins 
such as amoxicillin (AMX) by dental professionals has been 
reported, and the increase of bacterial isolates resistant to the 
former antibiotics is blamed for such a shift in prescription 
practices.[7] Fluoroquinolones are quinolone antimicrobials 
which are active against many β-lactam resistant bacteria. 
Amoxicillin/clavulanic acid (AMC), combination of a β-lactam 
antibiotic and β-lactamase inhibitor, has broad antimicrobial 
spectrum and eﬀ ective against AMX-resistant bacteria that 
produce β-lactamase.[8] Such antimicrobial agent may prove 
valuable for managing dental infections. Production of 
β-lactamase is, however, unusual for the most of streptococci, 
where resistance is happening by slight alteration in penicillin 
binding proteins.[9] Bacterial resistance to antibiotics such as 
penicillin and other β-lactam is a health issue in numerous parts 
of the world.
The use of herbs as drugs for the treatment of several diseases 
has been prevalent. Antibiotic resistance remains a dilemma. 
Segregation of microbial types, which are less resistant to 
antibiotic and also prevention of resistant strains to antibacterial 
treatments, has been intensifi ed worldwide. This fact shows 
that there is a need for novel principles in the treatment of 
bacterial infections[10] and the use of medicinal herbs, due to 
fewer complications and therapeutic eﬀ ects have become more 
important.[11]
It has been well-documented that medicinal plants confer 
antimicrobial activity toward oral bacteria.[12,13] The literature 
survey of the folklore medicine reveals the use of Cinnamomum 
zeylanicum, Acacia catechu, Mimusops elengi, and Terminalia 
arjuna to maintain oral hygiene and as an anticaries agent. 
Despite several anticaries agents being available commercially, 
the search for an eﬀective agent still continues. Natural products 
have shown to be a good alternative to synthetic chemical 
substances for caries prevention and to avoid side eﬀ ects. 
Therefore, nowadays, researchers across the globe are focusing 
on natural bioactive compounds that can mediate dental caries. 
Hence, this study was aimed to identify S. mutans from dental 
caries active subjects and to determine their susceptibility 
pattern to certain antibiotics. In addition to this, we reported 
inhibitory activity of bark of four medicinal plants against 
clinical isolates.
Methods
Specimen collection
The infected teeth samples from known dental caries patients 
were collected at the Department of Dentistry, District 
Government McGann Hospital, Shivamogga, Karnataka. The 
Samples were transferred into 2 ml of reduced transport fl uid 
medium (0.4% agar, 0.15% thioglycollate/phosphate buﬀ ered 
saline), brought to a laboratory and inoculated directly on blood 
agar by streaking method. The plates were incubated at 37°C for 
24-48 h. Characteristic colonies were picked from the plates and 
subcultured. Pure colonies were streaked on nutrient agar slopes, 
incubated at 37°C for 24 h. These slants were used as stock 
cultures and stored in the refrigerator for further biochemical 
tests.
Characterization of bacterial isolates
Identifi cation of the isolates was done using standard cultural, 
morphological, and biochemical characteristics as described 
in the Bergey’s Manual of Determinative Bacteriology. 
Further identifi cation was done by dextran production test 
and confi rmation of S. mutans was done by following the 
methodology of Gold et al.[14]
Antibiotic susceptibility testing of bacterial isolates
Antibiotic susceptibility test of the clinical isolates was 
done using modifi ed Kirby-Bauer disc diﬀ usion method in 
accordance with the guidelines of the Clinical and Laboratory 
Standards Institute.[15] The antibiotics used in this study 
include AMX, ciprofl oxacin (CIP), erythromycin (E), 
chloramphenicol (C), tetracycline (TE), vancomycin (VA), 
cefi xime (CFM), ampicillin (AM), clindamycin (CD), 
cefuroxime (CXM), bacitracin (B), spectinomycin (SPT), 
and kanamycin (K). The antimicrobial combinations used 
were AMC and AM/sulbactam (A/S). Bacterial inoculums 
were prepared by suspending the freshly grown bacteria in 
2 ml of sterile brain heart infusion broth with yeast extract, 
and the turbidity of tube was matched with 0.5 McFarland 
turbidity standards and then swabbed onto Mueller-Hinton 
agar plate. To prevent condensation, antibiotic discs were 
allowed to warm to ambient temperature before application. 
Within 15 min of inoculation, the antibiotic discs were placed 
fl at side down on the seeded agar surfaces using sterile forceps, 
followed by incubating agar plates for 24 h at 37°C. The 
relative susceptibility of the bacterial growth to each antibiotic 
shown by a clear zone of inhibition was measured in mm and 
zone diameter criterion was used to interpret the level of 
susceptibility to each antibiotic.
Collection of plant material
The bark of four medicinal plants, viz., C. zeylanicum, A. catechu, 
M. elengi, and T. arjuna were collected in and around of 
Shivamogga district, Karnataka. The plant materials were 
washed thoroughly, shade dried, and powdered in a blender. 
The powdered materials were stored in airtight containers for 
further extraction.
Preparation of plant extract
The powdered material of 500 g each was refl uxed successively, 
with the diﬀ erent organic solvents such as acetone, petroleum 
ether, chloroform, ethanol and distilled water in a Soxhlet extractor 
for 48 h. The extracts were concentrated in vacuum under reduced 
pressure on a rotary evaporator (Buchi, Switzerland), and then, 
the extracts were kept on water bath for complete evaporation of 
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solvent. The dried extracts were preserved in desiccators and used 
to determine antibacterial eﬃ  cacy.
Antibacterial screening
The antibacterial activity of solvent extracts of plants was 
screened at various concentrations (25 mg/ml, 50 mg/ml, and 
75 mg/ml) by agar well diﬀ usion technique. Mueller-Hinton 
agar (HiMedia) plates were swabbed using sterile cotton swabs, 
with 24 h old broth culture of clinical isolate S. mutans. Wells 
of 6 mm diameter and about 2 cm apart were made in each of 
these plates using sterile cork borer. About 100 μl of diﬀ erent 
concentrations of solvent extracts were added, with the help 
of sterile micropipette syringe into the wells and allowed to 
diﬀ use at room temperature for 2 h. Control experiments 
comprising of inoculums without extract were used. The plates 
were incubated at 37°C for 18 to 24 h, and the diameter of the 
inhibition zone was measured. Triplicates were maintained 
and the readings were taken in three diﬀ erent fi xed directions, 
and the average values were recorded. Commercially available 
chloramphenicol (1 mg/ml) was used as standard reference 
and 10% dimethyl sulfoxide as control. Antibacterial activity 
in terms of zone of inhibition was recorded after 24 h of 
incubation.
Results
The colonies showing alpha hemolysis were selected and were 
streaked on Mutans-Sanguis agar media. The white, gray, or 
yellow-colored colonies of 0.5-2 mm in diameter, rough, heaped, 
and irregular colonies resembling frosted glass were picked oﬀ  
and transferred to nutrient agar slants for further tests. Based 
on cultural, morphological, and biochemical characteristics as 
described in the Bergey’s manual of determinative bacteriology, 
the isolates were identifi ed as S. mutans [Table 1]. A total of 30 
S. mutans were recovered from infected teeth samples of known 
dental caries patients.
The susceptibility pattern of the clinical isolates against 
15 commercially used antimicrobial drugs [Table 2] in 
dentistry was assayed by Kirby-Bauer disc diﬀ usion method. All 
S. mutans isolates were sensitive against chloramphenicol, AMX, 
Erythromycin, CIP, TE, VA, SPT, AM, CD, and CXM, whereas 
least activity was shown by Bacitracin while CFM and kanamycin 
showed no inhibition zones [Table 3]. Combinations were used 
with an objective to broaden the spectrum of antimicrobial 
action. Among the antimicrobial combinations used: The 
greatest potency was shown by A/S followed by AMC. Among 
the antibacterial drugs tested, chloramphenicol showed 
maximum zone of inhibition followed by AMX, Erythromycin, 
and CIP [Figure 1]. All S. mutans isolates were resistant to CFM 
and kanamycin.
The in vitro antibacterial potential of four medicinal plants 
against 30 clinical isolates of S. mutans was carried out by agar 
well diﬀ usion method and results were tabulated. This study is 
a preliminary assessment of the easily available medications of 
Table 1: Characterization of S. mutans isolates
Test Result Test Result
Gram-stain Gram-positive Urea hydrolysis Negative
Shape Cocci Voges-Proskauer 
test
Positive
Motility Nonmotile Optochin 
sensitivity
Negative
Oxygen 
requirements
Facultative 
anaerobic
Growth on 
6.5%NaCl
Negative
Catalase Negative Acid from:
Hemolysis α and β Sucrose Positive
Esculin 
hydrolysis
Positive Mannitol Positive
Arginine 
hydrolysis
Negative Lactose Positive
Glucan Positive Sorbitol Positive
S. mutans: Streptococcus mutans
Table 2: Th e antibiotics used and their disc potency
Antibiotic Symbol Disc potency 
(mcg)
Chloramphenicol C 25
Amoxicillin AMX 25
Erythromycin E 15
Ciprofl oxacin CIP 5
Tetracycline TE 30
Vancomycin VA 30
Spectinomycin SPT 100
Ampicillin AM 25
Clindamycin CD 2
Cefuroxime CXM 30
Cefi xime CFM 05
Bacitracin B 10
Kanamycin K 30
Ampicillin/sulbactam A/S 10/10
Amoxicillin/clavulanic
acid
AMC 30
Figure  1: Antibiogram profi le of Streptococcus mutans against 
various antibiotics
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plant origin which can be eﬀ ective in the treatment of dental 
caries, and the results showed variation in the antibacterial 
properties of diﬀ erent medicinal plant extracts.
The results revealed that different solvent extracts of 
bark of C. zeylanicum showed a dose-dependent significant 
inhibitory effect against all the isolates [Table 4]. Among 
these extracts, acetone extract at 75 mg/ml concentration 
exhibited remarkable inhibitory effect, i.e., 32.5 ± 0.42 mm 
compared to standard antibiotic chloramphenicol. Whereas 
ethanol extract showed moderate activity followed by 
aqueous extract which exhibited mild effect against clinical 
isolates [Figure 2].
The bark of A. catechu extracts exhibited potent activity 
against all the test isolates. The chloroform and ethanol 
extract at 75 mg/ml concentration showed significant 
inhibitory activity 30.4 ± 0.27 mm and 31.5 ± 0.30 mm, 
respectively, and the values obtained indicated that the 
responses were dose-dependent [Table 5]. The acetone 
extract showed mild effect, whereas petroleum ether extract 
was found to be moderate.
Table 3: Antibiotics susceptibility pattern of the isolates
Isolate 
number
Antibiotics  (zone of inhibition in mm)
AMX CIP E TE VA C CD SPT AM CXM B CFM K A/S AMC
S1 29 20 22 22 20 31 20 18 20 25 NZ NZ NZ 35 28
S2 27 20 23 21 22 29 20 19 23 23 NZ NZ NZ 34 29
S3 30 21 21 24 21 32 18 17 22 24 8 NZ NZ 36 26
S4 31 23 20 25 19 33 22 15 21 26 NZ NZ NZ 32 27
S5 24 22 23 25 28 26 23 15 20 25 6 NZ NZ 36 25
S6 25 24 24 21 26 28 20 16 25 23 NZ NZ NZ 37 26
S7 28 22 25 22 25 30 19 17 20 26 6 NZ NZ 35 30
S8 32 20 25 23 21 35 20 19 26 25 6 NZ NZ 35 32
S9 26 22 26 25 23 27 24 20 22 24 5 NZ NZ 36 31
S10 32 21 21 24 24 35 18 18 26 24 5 NZ NZ 34 30
S11 31 21 24 26 22 34 18 19 27 25 4 NZ NZ 38 35
S12 34 24 23 22 22 37 19 19 25 26 4 NZ NZ 35 23
S13 33 22 22 27 23 35 23 20 26 22 6 NZ NZ 36 34
S14 34 23 20 21 25 36 21 20 22 27 7 NZ NZ 40 35
S15 36 22 26 23 21 38 20 18 24 23 5 NZ NZ 36 36
S16 32 20 25 22 19 34 20 16 23 252 6 NZ NZ 36 35
S17 34 21 20 25 19 36 19 20 25 28 6 NZ NZ 35 36
S18 32 22 21 26 22 35 21 21 23 23 5 NZ NZ 37 35
S19 36 25 27 21 19 39 20 19 26 25 5 NZ NZ 32 34
S20 33 22 26 24 25 36 18 18 28 24 8 NZ NZ 33 35
S21 38 20 21 23 17 40 21 16 22 23 5 NZ NZ 37 36
S22 39 23 20 22 23 41 20 22 26 26 4 NZ NZ 36 35
S23 40 21 24 24 17 43 19 20 25 22 5 NZ NZ 35 35
S24 34 23 22 22 23 36 22 21 24 25 6 NZ NZ 35 36
S25 35 22 22 21 24 38 25 18 23 24 4 NZ NZ 34 32
S26 37 20 23 25 19 40 20 17 22 23 5 NZ NZ 36 37
S27 41 21 24 26 25 43 22 20 29 22 5 NZ NZ 35 36
S28 39 23 20 22 21 41 23 23 22 28 6 NZ NZ 38 38
S29 41 22 22 25 26 43 22 22 24 26 NZ NZ NZ 36 35
S30 38 21 25 22 20 40 20 21 26 23 NZ NZ NZ 32 32
NZ: No zone of inhibition, AMX: Amoxicillin, C: Chloramphenicol, E: Erythromycin, CIP: Ciprofloxacin, TE: Tetracycline, VA: Vancomycin, 
SPT: Spectinomycin, AM: Ampicillin, CD: Clindamycin, CXM: Cefuroxime, CFM: Cefixime, B: Bacitracin, K: Kanamycin, A/S: Ampicillin/sulbactam, 
AMC: Amoxicillin/clavulanic acid
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The acetone and ethanol extract of bark of M. elengi showed 
similar antibacterial activity at 75 mg/ml concentration 
[Table 6]. Whereas the aqueous extract was found to be less 
eﬀ ective to inhibit the growth of S. mutans compared to other 
solvent extracts. The acetone extract of bark of T. arjuna 
demonstrated good inhibitory activity followed by ethanol 
extract and the negligible eﬀ ect was exhibited by aqueous extract 
[Table 7].
Discussion
Mutans group of Streptococci resistant to antibiotics have 
increasingly been reported over the past decade, whereas 
studies on antibiotic resistance of S. mutans are few. At present, 
recommendations of choice antimicrobial agents for particular 
forms of dental infections are based on published data. Although 
there is an increasing and continuing of microbial resistance 
to usual antibiotics, we found that all S. mutans isolates were 
sensitive to the tested antibiotics except CFM and kanamycin. 
Jarvinen studied the susceptibility of S. mutans to chlorhexidine 
and six frequently prescribed antibiotics (AMX, CXM, penicillin, 
sulfamethoxazole trimethoprim, TE, and erythromycin) for 424 
clinical isolates, and there was no resistance to the antimicrobial 
agents.[16] Agents in the penicillin group, principally 
phenoxymethylpenicillin and AMX, traditionally have been 
regarded as the antimicrobials of choice in the treatment of acute 
dental infections, whereas erythromycin traditionally has been 
used as an alternative agent for patients with hypersensitivity 
to penicillin. S. mutans have been found to be susceptible 
against AMX as revealed by the data, and the maximum zone 
of inhibition was found to be 31 mm. According to Pranay and 
Ram,[17] AMX gave 44-45 mm zone of inhibition, and his study 
showed that CIP was resistant, but according to our study, CIP 
showed 24 mm zone of inhibition against the isolates. In the 
present study, they were no AM resistance bacteria detected, 
whereas, in an earlier study by Dhamodhar et al.,[18] they have 
reported 100% of S. mutans resistant to penicillin and AM 
antibiotics but the resistance developed by S. mutans is obscure.
AMC, combination of a β-lactam antibiotic and β-lactamase 
inhibitor, has broad antimicrobial spectrum and eﬀ ective against 
AMX-resistant bacteria that produce β-lactamase.[19] Such 
antimicrobial agent may prove valuable for managing dental 
infections. The sensitivity for VA was found to be equivalent to 
that of AMC, suggesting its role in diﬃ  cult to treat infections. 
Its regular use should be avoided to prevent the development of 
resistance. Erythromycin has been recommended as alternative 
options for patients who are allergic to penicillin and are also 
widely used for antibiotic prophylaxis of endocarditis associated 
with dental procedures. This antibiotic has not developed 
resistance against the strains of S. mutans as revealed by the 
zone of inhibition in the present study. CD is eﬀ ective against 
β-hemolytic streptococci (Groups A, B, C, and G), Streptococcus 
viridans group, and members of the S. milleri. The TEs are broad 
spectrum antibiotics that act by inhibiting bacterial protein 
synthesis. They are relatively inexpensive drugs and have been 
extensively used in the prophylactic and therapeutic regimens. 
TE shows side eﬀ ects mainly on the digestive system which 
include mild stomach pain or upset, nausea, vomiting, and 
diarrhea. These antibiotics have selective aﬃ  nity for deposition 
in tooth substance, possibly through the formation of a complex 
with calcium ions of hydroxyapatite crystals; leading to tooth 
discoloration.[19] However, as eﬀ ective in inhibiting the growth of 
S. mutans and hence should be recommended for use. Therefore, 
pertaining to dental infections, such antibiotics must be used 
with caution. Further investigations are required to attempt to 
slow resistance development and lessen the future impact on 
antibiotic prescribing in dentistry. These results call for improved 
inspection of antibiotic susceptibility testing during prophylaxis 
Table 4: Antibacterial activity of various solvent extracts of bark of C. zeylanicum against S. mutans
Isolate Zone of inhibition  (mm)
Acetone extract (%) Ethanol extract (%) Aqueous extract (%) 10% 
DMSO
Standard
25 50 75 25 50 75 25 50 75
S. mutans 
n=30
18.5±0.35 25.3±0.36 32.5±0.42 17.5±0.25 24.6±0.40 30.3±0.51 14.3±0.40 20.6±0.43 26.3±0.45 0.0 35.2±0.23
Each value is the mean of three replicate determinations±standard deviation. C. zeylanicum: Cinnamomum zeylanicum, S. mutans: Streptococcus mutans, 
DMSO: Dimethyl sulfoxide
Figure 2: Antibacterial activity of ethanol extract of diff erent plants 
against Streptococcus mutans (S - Standard antibiotic; C - Control)
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and the choice of antibiotic such as herbal extract is most likely 
preferable for the coming years to avoid the upcoming bacterial 
resistance to the antibiotics.
The antimicrobial potency of plants is believed to be due 
to tannins, saponins, phenolic compounds, essential oils, and 
fl avonoids.[20] It is interesting to note that even crude extracts of 
these plants showed good inhibitory activity against multidrug 
resistant strains where modern antibiotic therapy has failed.
In the present investigation, C. zeylanicum showed maximum 
antibacterial activity against S. mutans followed by A. catechu, 
M. elengi, and T. arjuna. The antimicrobial activity of C. zeylanicum 
is attributed to the presence of cinnamaldehyde which is the 
predominant active component found in cinnamon oil.[21] 
A. catechu is useful as a topical agent for sore gums and mouth 
ulcers. The heartwood extract is found to have broad spectrum 
antimicrobial activity and ethanol extract proved its eﬃ  cacy 
as a potent antibacterial agent. The phytochemical studies of 
A. catechu showed the presence of alkaloids, carbohydrates, 
fl avones, phenolic compounds, steroids, and tannins which may 
be responsible for its antimicrobial activity.[22] Along with this, 
taxifolin extracted from this plant showed an inhibitory eﬀ ect 
against S. mutans and lactobacillus acidophilus. Preclinical studies 
by Ajaybhan have shown that the petroleum ether, acetone, 
methanol, and aqueous extracts of the M. elengi were eﬀ ective 
on the S. aureus, S. mutans, S. salivarius, S. sanguis, L. acidophilus, 
and Candida albicans. Among the four extracts, the methanol 
extract was observed to be the most potent followed by aqueous, 
acetone, and petroleum ether extracts.[23] However, according 
to Khan et al.,[24] a crude ethanol extract of T. arjuna bark was 
not active against a Gram-negative bacteria and S. mutans and 
C. albicans.
This study reveals that the acetone extract of C. zeylanicum 
and ethanol extract of A. catechu could be used as a potential 
source of new antimicrobials as it showed dose-dependent 
activity and scientifi cally validates the use of these extracts in 
traditional medicine.
Conclusion
This investigation may help to suggest alternative possible 
antibiotics for the treatment of dental caries in our locality in 
place of the commonly abused ones, and it may be emphasized 
here that in vitro antimicrobial susceptibility testing results 
for dental isolates need standardization with further studies. 
Continue surveillance in the form of routine susceptibility tests is 
an excellent source of information on the prevalence of resistant 
pathogens within dental caries. The current study pointed out 
that there is a great need to monitor antimicrobial resistance of 
bacterial isolates at time interval regularly. We have shown that 
acetone extract of C. zeylanicum and ethanol extract of A. catechu 
exhibited the signifi cant antibacterial activity against S. mutans. 
The results also indicated the necessity for further investigation 
to isolate and characterize active principle responsible for the 
activity.Ta
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Table 6: Antibacterial activity of various solvent extracts of bark of M. elengi against S. mutans
Isolate Zone of inhibition  (mm)
Acetone extract (%) Ethanol extract (%) Aqueous extract (%) 10% 
DMSO
Standard
25 50 75 25 50 75 25 50 75
S. mutans 
n=30
10.5±0.42 14.5±0.34 19.5±0.53 10.2±0.37 14.1±0.25 19.2±0.31 7.1±0.30 11.4±0.29 16.1±0.25 0.0 35.2±0.23
Each value is the mean of three replicate determinations±standard deviation. M. elengi: Mimusops elengi, DMSO: Dimethyl sulfoxide, S. mutans: Streptococcus 
mutans
Table 7: Antibacterial activity of various solvent extracts of bark of T. arjuna against S. mutans
Isolate Zone of inhibition  (mm)
Acetone extract (%) Ethanol extract (%) Aqueous extract (%) 10% 
DMSO
Standard
25 50 75 25 50 75 25 50 75
S. mutans 
n=30
8.2±0.40 12.2±0.49 18.8±0.54 8.5±0.41 11.3±0.45 17.1±0.44 6.2±0.12 8.8±0.63 11.8±0.65 0.0 35.2±0.23
Each value is the mean of three replicate determinations±standard deviation. T. arjuna: Terminalia arjuna, S.mutans: Streptococcus mutans, DMSO: Dimethyl 
sulfoxide
How to cite this article: Prabhuswamy B, Mallikarjun N, 
Nagaraj K, Venugopal TM, Somasundar K. Antibiogram 
profi le and antibacterial eﬃ  cacy of medicinal plant extracts 
on Streptococcus mutans: An in vitro study. Int J Clin Den Sci 
2016;7:1-7.
